| Product Name | EBV VCA IgG rapid assay kit |
| Catalog No. | CA-00182 |
| Description | The EBV VCA IgG rapid assay kit is a diagnostic tool used to quickly detect the presence of EBV VCA IgG in humans. |
| Application | This product can be used for rapid in vitro screening of EBV VCA IgG. |
| Operating Temperature | Store at 4-30°C. |
| Transportation Condition | Transportation at room temperature. |
Discovery and Significance: The Epstein-Barr virus (EBV) was first discovered in 1964 by Michael Anthony Epstein and Yvonne M. Barr. It is a member of the herpesvirus family and is one of the most common human viruses. EBV is associated with several diseases, including infectious mononucleosis, certain types of cancers such as Burkitt's lymphoma and nasopharyngeal carcinoma, and autoimmune diseases. The discovery of EBV has significantly advanced our understanding of viral oncogenesis and the immune response to chronic viral infections.
Viral Capsid Antigen (VCA): VCA is a major antigenic component of the EBV virion. It is produced during both the lytic and latent phases of the viral life cycle. The presence of VCA IgG antibodies in the blood is a reliable indicator of past or ongoing EBV infection. Detecting VCA IgG is crucial for diagnosing EBV-related diseases and monitoring the immune status of individuals who have been exposed to the virus.
Role in Diagnosis: The EBV VCA IgG rapid assay kit plays a vital role in clinical settings by providing a quick and convenient method to detect VCA IgG antibodies. This allows healthcare providers to make timely and accurate diagnoses, initiate appropriate treatment, and manage patient care effectively. The ability to rapidly screen for EBV VCA IgG antibodies is particularly important in emergency departments, primary care clinics, and research laboratories where prompt results are essential.
·Rapid Results: Delivers accurate results in just 10-15 minutes, enabling quick decision-making.
·User-Friendly Design: Simple to use with minimal training required, making it suitable for both laboratory technicians and healthcare providers in various settings.
·High Sensitivity and Specificity: Utilizes advanced immunochromatographic technology to ensure reliable detection of EBV VCA IgG antibodies.
·Room Temperature Storage: Convenient storage conditions (4-30°C) eliminate the need for refrigeration, reducing storage costs and logistical challenges.
·Stable During Transportation: Maintains stability at room temperature during transportation, ensuring the integrity of the test kit.
·Time-Efficient: Provides rapid results, allowing for immediate patient management and treatment decisions.
·Cost-Effective: Combines affordability with high performance, making it an economical choice for routine screening and diagnostic purposes.
·Wide Application: Suitable for a variety of settings, including hospitals, clinics, research institutions, and field laboratories.
·Ease of Use: Requires no specialized equipment or complex procedures, facilitating widespread adoption and use.
·Reliable Performance: Backed by rigorous quality control and validation studies, ensuring consistent and dependable results.
For in vitro diagnostic use.
|
There is no product in your cart. |
Copyright © 2025 Alta DiagenoTech. All rights reserved.
